Your browser doesn't support javascript.
loading
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
Ueno, Makoto; Morizane, Chigusa; Okusaka, Takuji; Mizusawa, Junki; Kataoka, Tomoko; Ikeda, Masafumi; Ozaka, Masato; Okano, Naohiro; Sugimori, Kazuya; Todaka, Akiko; Shimizu, Satoshi; Mizuno, Nobumasa; Yamamoto, Tomohisa; Sano, Keiji; Tobimatsu, Kazutoshi; Katanuma, Akio; Miyamoto, Atsushi; Yamaguchi, Hironori; Nishina, Tomohiro; Shirakawa, Hirofumi; Kojima, Yasushi; Oono, Takamasa; Kawamoto, Yasuyuki; Furukawa, Masayuki; Iwai, Tomohisa; Sudo, Kentaro; Miyakawa, Hiroyuki; Yamashita, Tatsuya; Yasuda, Ichirou; Takahashi, Hidenori; Kato, Naoya; Shioji, Kazuhiko; Shimizu, Kyoko; Nakagohri, Toshio; Kamata, Ken; Ishii, Hiroshi; Furuse, Junji.
Afiliación
  • Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi ku, Yokohama, 241-0815, Japan. makoto23u@gmail.com.
  • Morizane C; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Mizusawa J; Japan Clinical Oncology Group/Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kataoka T; Japan Clinical Oncology Group/Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Ozaka M; Hepato-Biliary-Pancreatic Medicine Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Okano N; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Mitaka, Tokyo, Japan.
  • Sugimori K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Sunto-Gun, Shizuoka, Japan.
  • Shimizu S; Department of Gastroenterology, Saitama Cancer Center, Kita-Adachi-Gun, Saitama, Japan.
  • Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yamamoto T; Department of Surgery, Kansai Medical University Hospital, Hirakata, Osaka, Japan.
  • Sano K; Department of Surgery, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan.
  • Tobimatsu K; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Katanuma A; Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Miyamoto A; Department of Hepatobiliary and Pancreatic Surgery, Osaka National Hospital, Osaka, Japan.
  • Yamaguchi H; Department of Surgery, Jichi Medical University, Shimono, Tochigi, Japan.
  • Nishina T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Shirakawa H; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Kojima Y; Department of Gastroenterology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Oono T; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kawamoto Y; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Furukawa M; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Iwai T; Department of Gastroenterology, Kitasato University Hospital, Sagamihara, Kanagawa, Japan.
  • Sudo K; Gastrointestinal Medical Oncology, Chiba Cancer Center, Chiba, Japan.
  • Miyakawa H; Department of Bilio-Pancreatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
  • Yamashita T; Department of Gastroenterology, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Yasuda I; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Shioji K; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
  • Shimizu K; Department of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
  • Nakagohri T; Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Kamata K; Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan.
  • Ishii H; Gastrointestinal Medical Oncology, Chiba Cancer Center, Chiba, Japan.
  • Furuse J; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Mitaka, Tokyo, Japan.
Sci Rep ; 11(1): 12885, 2021 06 18.
Article en En | MEDLINE | ID: mdl-34145336
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article